Shen-hong Qu
Department Of Otolaryngology & Head And Neck
Nanning, China
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Penpulimab and Gemcitabine With or Without Anlotinib in Metastatic Nasopharyngeal Carcinoma: A Randomized, Open-Label, Multicenter Phase 2 Study.
Journal: International journal of cancer
Published: November 06, 2025
Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial.
Journal: Med (New York, N.Y.)
Published: October 02, 2025
Overexpression of STOML1 is associated with good prognosis in nasopharyngeal carcinoma.
Journal: Oncology letters
Published: October 25, 2024
Symptom clusters after chemoradiotherapy in discharged nasopharyngeal carcinoma patients.
Journal: Frontiers in oncology
Published: May 20, 2022
STAT3 regulates SRGN and promotes metastasis of nasopharyngeal carcinoma through the FoxO1-miR-148a-5p-CREB1 axis.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: July 26, 2021
Effects of Surgery Combined with Chemoradiotherapy on Short- and Long-Term Outcomes of Early-Stage Nasopharyngeal Carcinoma.
Journal: Cancer management and research
Published: May 28, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026